SCHEMBL6918276

SCHEMBL6918276

COc1c(Cl)ncnc1Nc1ccc(N)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.46
KDR P35968 2/20 0.45
FLT1 P17948 1/20 0.45
ESR1 P03372 1/20 0.44
TTBK1 Q5TCY1 4/20 0.43
TTBK2 Q6IQ55 4/20 0.43
EGFR P00533 5/20 0.43
PDPK1 O15530 1/20 0.43
MAPT P10636 4/20 0.42
ALDH1A1 P00352 2/20 0.42
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
GRM1 Q13255 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 2/20 0.40
RAB9A P51151 2/20 0.40
NPC1 O15118 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ADORA3 P0DMS8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27962184 0.83 CA1 (0.62) KDREGFRLMNACA1CA2
SCHEMBL9607630 0.82 ABCG2 (0.50) KDRFLT1TTBK1TTBK2EGFR
SCHEMBL27971500 0.77 ESR1 (0.74) ESR1ALDH1A1MAPK1SMN1; SMN2KDM4E
SCHEMBL6918294 0.76 F9 (0.52) NR4A1ESR1TTBK1TTBK2EGFR
SCHEMBL9046753 0.74 PGK1 (0.41) EGFRPDPK1MAPTALDH1A1POLB
SCHEMBL17815587 0.74 GALR3 (0.58) TTBK1TTBK2EGFRMAPTALDH1A1
SCHEMBL6345655 0.74 PIK3CA (0.50) MAPTALDH1A1POLBGAAL3MBTL1
SCHEMBL23357588 0.74 BCL6 (0.53) MAPTALDH1A1HTTSMN1; SMN2LMNA
SCHEMBL1896427 0.73 TTBK1 (0.55) KDRFLT1TTBK1TTBK2EGFR
SCHEMBL16257538 0.73 EGFR (0.61) EGFRMAPTMAPK1HTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011017296-A1 4, 5, 6-TRISUBSTITUTED PYRIMIDINE DERIVATIVES AS FACTOR IXA INHIBITORS SCHERING CORPORATION (US) 2011-02-10 WO disclosed